Page last updated: 2024-08-23

paroxetine and methionine

paroxetine has been researched along with methionine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Dahmen, N; Kohnen, R; Müller, MJ; Rujescu, D; Stassen, HH; Szegedi, A; Tadic, A1
Arias, B; Catalán, R; Fañanás, L; Gastó, C; Lorenzi, C; Serretti, A1

Reviews

1 review(s) available for paroxetine and methionine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

3 other study(ies) available for paroxetine and methionine

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression.
    The pharmacogenomics journal, 2005, Volume: 5, Issue:1

    Topics: Adult; Catechol O-Methyltransferase; Depressive Disorder, Major; Female; Humans; Male; Methionine; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Polymorphism, Genetic; Time Factors; Valine

2005
Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin.
    Journal of affective disorders, 2006, Volume: 90, Issue:2-3

    Topics: Antidepressive Agents, Second-Generation; Biological Availability; Catechol O-Methyltransferase; Citalopram; Depressive Disorder, Major; Dopamine; Ethnicity; Female; Fluvoxamine; Follow-Up Studies; Frontal Lobe; Genetic Carrier Screening; Genotype; Humans; Male; Methionine; Paroxetine; Personality Inventory; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Valine

2006